Showing results (21-30 of 188) with videos related to
Sort By:
Pageof 19
Neuropsychobiology|January 1, 1976
Alpha-methyldopa-chlorpromazine combination in schizophrenic patientsG Chouinard, L AnnableJournal of Clinical Psychopharmacology|April 1, 1986
An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorderR Fontaine, G ChouinardSchizophrenia Research|August 27, 1999
A rating scale for psychotic symptoms (RSPS) part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations)G Chouinard, R MillerThe Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 16, 1999
Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical PharmacologyJ Nelson, G ChouinardBiological Psychiatry|November 15, 1993
Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophreniaR Miller, G ChouinardCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 1, 1991
A guide to benzodiazepine selection. Part II: Clinical aspectsE Teboul, G ChouinardCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 1, 1993
Clinical review of risperidoneG Chouinard, W ArnottThe Journal of Clinical Psychiatry|August 1, 1985
Schizophreniform psychosis associated with chronic industrial toluene exposure: case reportD Goldbloom, G ChouinardPsychopharmacology|January 1, 1982
Pimozide in the treatment of newly admitted schizophrenic patientsG Chouinard, L AnnableCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1990
A guide to benzodiazepine selection. Part I: Pharmacological aspectsE Teboul, G ChouinardPageof 19